232 related articles for article (PubMed ID: 15294075)
41. Analysis of interaction between RNA aptamer and protein using nucleotide analogs.
Sekiya S; Fukuda K; Hwang J; Kakiuchi N; Taira K; Kusakabe I; Nishikawa S
Nucleic Acids Symp Ser; 2000; (44):163-4. PubMed ID: 12903319
[TBL] [Abstract][Full Text] [Related]
42. The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target.
Frick DN
Curr Issues Mol Biol; 2007 Jan; 9(1):1-20. PubMed ID: 17263143
[TBL] [Abstract][Full Text] [Related]
43. Optimization of the multiple enzymatic activities of the hepatitis C virus NS3 protein.
Misialek S; Rajagopalan R; Stevens SK; Beigelman L; Seiwert SD; Kossen K
Anal Biochem; 2009 Nov; 394(1):138-40. PubMed ID: 19591800
[TBL] [Abstract][Full Text] [Related]
44. Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus.
Urvil PT; Kakiuchi N; Zhou DM; Shimotohno K; Kumar PK; Nishikawa S
Eur J Biochem; 1997 Aug; 248(1):130-8. PubMed ID: 9310370
[TBL] [Abstract][Full Text] [Related]
45. Towards defining a minimal functional domain for NTPase and RNA helicase activities of the hepatitis C virus NS3 protein.
Kim DW; Gwack Y; Han JH; Choe J
Virus Res; 1997 May; 49(1):17-25. PubMed ID: 9178493
[TBL] [Abstract][Full Text] [Related]
46. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity.
Kim DW; Gwack Y; Han JH; Choe J
Biochem Biophys Res Commun; 1995 Oct; 215(1):160-6. PubMed ID: 7575585
[TBL] [Abstract][Full Text] [Related]
47. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA.
Kumar PK; Machida K; Urvil PT; Kakiuchi N; Vishnuvardhan D; Shimotohno K; Taira K; Nishikawa S
Virology; 1997 Oct; 237(2):270-82. PubMed ID: 9356339
[TBL] [Abstract][Full Text] [Related]
48. Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action.
Lam AM; Keeney D; Frick DN
J Biol Chem; 2003 Nov; 278(45):44514-24. PubMed ID: 12944414
[TBL] [Abstract][Full Text] [Related]
49. Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase.
Furuta A; Tsubuki M; Endoh M; Miyamoto T; Tanaka J; Salam KA; Akimitsu N; Tani H; Yamashita A; Moriishi K; Nakakoshi M; Sekiguchi Y; Tsuneda S; Noda N
Int J Mol Sci; 2015 Aug; 16(8):18439-53. PubMed ID: 26262613
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding.
Kim JL; Morgenstern KA; Griffith JP; Dwyer MD; Thomson JA; Murcko MA; Lin C; Caron PR
Structure; 1998 Jan; 6(1):89-100. PubMed ID: 9493270
[TBL] [Abstract][Full Text] [Related]
51. The serine protease domain of hepatitis C viral NS3 activates RNA helicase activity by promoting the binding of RNA substrate.
Beran RK; Serebrov V; Pyle AM
J Biol Chem; 2007 Nov; 282(48):34913-20. PubMed ID: 17921146
[TBL] [Abstract][Full Text] [Related]
52. Coupling translocation with nucleic acid unwinding by NS3 helicase.
Yu J; Cheng W; Bustamante C; Oster G
J Mol Biol; 2010 Dec; 404(3):439-55. PubMed ID: 20887735
[TBL] [Abstract][Full Text] [Related]
53. Characterization of classical swine fever virus (CSFV) nonstructural protein 3 (NS3) helicase activity and its modulation by CSFV RNA-dependent RNA polymerase.
Wen G; Xue J; Shen Y; Zhang C; Pan Z
Virus Res; 2009 Apr; 141(1):63-70. PubMed ID: 19185595
[TBL] [Abstract][Full Text] [Related]
54. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
[TBL] [Abstract][Full Text] [Related]
55. Toward the mechanism of dynamical couplings and translocation in hepatitis C virus NS3 helicase using elastic network model.
Zheng W; Liao JC; Brooks BR; Doniach S
Proteins; 2007 Jun; 67(4):886-96. PubMed ID: 17373706
[TBL] [Abstract][Full Text] [Related]
56. Robust translocation along a molecular monorail: the NS3 helicase from hepatitis C virus traverses unusually large disruptions in its track.
Beran RK; Bruno MM; Bowers HA; Jankowsky E; Pyle AM
J Mol Biol; 2006 May; 358(4):974-82. PubMed ID: 16569413
[TBL] [Abstract][Full Text] [Related]
57. Integrated strategies for identifying leads that target the NS3 helicase of the hepatitis C virus.
LaPlante SR; Padyana AK; Abeywardane A; Bonneau P; Cartier M; Coulombe R; Jakalian A; Wildeson-Jones J; Li X; Liang S; McKercher G; White P; Zhang Q; Taylor SJ
J Med Chem; 2014 Mar; 57(5):2074-90. PubMed ID: 24467709
[TBL] [Abstract][Full Text] [Related]
58. NS3 from Hepatitis C Virus Strain JFH-1 Is an Unusually Robust Helicase That Is Primed To Bind and Unwind Viral RNA.
Zhou T; Ren X; Adams RL; Pyle AM
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070684
[TBL] [Abstract][Full Text] [Related]
59. Preparation of HCV NS3 and NS5B proteins to support small-molecule drug discovery.
Hung M; Wang R; Liu X
Curr Protoc Pharmacol; 2011 Sep; Chapter 13():Unit13B.6. PubMed ID: 21898331
[TBL] [Abstract][Full Text] [Related]
60. NS3 Peptide, a novel potent hepatitis C virus NS3 helicase inhibitor: its mechanism of action and antiviral activity in the replicon system.
Gozdek A; Zhukov I; Polkowska A; Poznanski J; Stankiewicz-Drogon A; Pawlowicz JM; Zagórski-Ostoja W; Borowski P; Boguszewska-Chachulska AM
Antimicrob Agents Chemother; 2008 Feb; 52(2):393-401. PubMed ID: 18039921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
